Inventor · disambiguated record
Monsif Bouaboula
Also filed as: BOUABOULA MONSIF
6 granted patents·20 pending applications·49 citations·filing 2008–2025
83Inventor score
Top patents by PatentIndex Score
26 records- 0196US11214541B2Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2020·Granted Jan 4, 2022·7 cites·20 claims
- 0296US9714221B1Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2017·Granted Jul 25, 2017·18 cites·17 claims
- 0395US10570090B2Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2017·Granted Feb 25, 2020·10 cites·24 claims
- 0491US11149031B2Substituted N-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2019·Granted Oct 19, 2021·6 cites·16 claims
- 0588US11260057B2Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7] annulene-2-carboxylic acid and its use for the treatment of cancerSANOFI SA·Filed 2018·Granted Mar 1, 2022·8 cites·11 claims
- 0685US2024150284A1Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses ThereofSANOFI SA·Filed 2023·Application pending·0 cites
- 0780US2025368605A1Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses ThereofSANOFI SA·Filed 2025·Application pending·0 cites
- 0878US2022073460A1Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses ThereofSANOFI SA·Filed 2021·Application pending·0 cites
- 0972US2020392081A1Novel substituted 6,7-dihydro-5h-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2020·Application pending·0 cites
- 1064US2022204488A1Novel Substituted N-(3-Fluoropropyl)-Pyrrolidine Compounds, Processes for their Preparation and Therapeutic Uses ThereofSANOFI SA·Filed 2021·Application pending·0 cites
- 1160US2022362248A1Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7] annulene-2-carboxylic acid and its use for the treatment of cancerSANOFI SA·Filed 2022·Application pending·0 cites
- 1257US12427142B2Combination comprising alpelisib and 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl[oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acidSANOFI SA·Filed 2021·Granted Sep 30, 2025·0 cites·19 claims
- 1355US2024197692A1Combination Comprising Everolimus and AmcenestrantSANOFI SA·Filed 2022·Application pending·0 cites
- 1455US2024197739A1Combination Comprising Ribociclib and AmcenestrantSANOFI SA·Filed 2022·Application pending·0 cites
- 1555US2024002950A1Panel of ER Regulated Genes for Use in Monitoring Endocrine Therapy in Breast CancerSANOFI SA·Filed 2021·Application pending·0 cites
- 1655US2023404971A1Combination Comprising Abemaciclib and 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylic AcidSANOFI SA·Filed 2021·Application pending·0 cites
- 1752US2010099694A12-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitorsSANOFI AVENTIS·Filed 2009·Application pending·0 cites
- 1851US2010035907A1New 2,4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitorsSANOFI AVENTIS·Filed 2009·Application pending·0 cites
- 1949US2010093668A1N,n'-2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitorsSANOFI AVENTIS·Filed 2009·Application pending·0 cites
- 2048US2010069417A1Novel phenyl(4-phenylpyrimidin-2-yl)amine derivatives, their preparation, as medicaments, pharmaceutical compositions and in particular as ikk inhibitorsSANOFI AVENTIS·Filed 2009·Application pending·0 cites
- 2146US2008269170A1Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK InhibitorsSANOFI AVENTIS·Filed 2008·Application pending·0 cites
- 2239US2011251194A1Antineoplastic derivatives, preparation thereof and therapeutic use thereofSANOFI AVENTIS·Filed 2011·Application pending·0 cites
- 2329US2010222319A1Nicotinamide derivatives, preparation thereof and therapeutic use thereofSANOFI AVENTIS·Filed 2010·Application pending·0 cites
- 2421US2012053170A1Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugsARIGON JEROME·Filed 2010·Application pending·0 cites
- 2521US2012094986A1Anticancer deriviatives, preparation thereof, and therapeutic use thereofARIGON JEROME·Filed 2010·Application pending·0 cites
- 2621US2012053209A1Anticancer compounds, preparation thereof, and therapeutic use thereofARIGON JEROME·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Monsif Bouaboula files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →